Jason Hurt
Chief Medical Officer NAYA Therapeutics
Jason is a Chief Medical Officer and oncology and radiopharmaceutical specialist with extensive, end-to-end drug development experience, combining deep clinical expertise with strong business acumen. A data-driven and values-led leader, he is known for building high-performing teams and driving impactful decision-making to deliver optimal patient outcomes.
Thursday 17th September 2026
Why Manufacturing Progress Alone Will Not Deliver Radiopharmaceutical Therapies to Patients
12:00 pm
This interactive mastermind session will begin with a short presentation to challenge current industry assumptions, followed by a facilitated audience discussion where participants will collaboratively assess where the supply chain breaks today and share practical strategies to better align manufacturing, clinical operations, and patient delivery.
- Challenging the industry’s focus on isotope production by examining where the system actually fails in practice, from limited clinical trial site readiness and patient coordination, to gaps between manufacturing output and real-world delivery capability
- Defining what it takes to truly “close the loop” between manufacturing, logistics, and patient administration, ensuring coordination across stakeholders so that therapies can reliably move from production to patient treatment
- Identifying how organizations can standardize site activation, training, and support to move beyond a limited number of specialized centers and enable broader trial access
